Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04300998 · ClinicalTrials.gov registry record
Study of CAR-T Therapy in Older Patients
A clinical trial of Multiple Myeloma and Lymphoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 154
- Enrollment target
- 1
- Study location
NCT04300998: Recruiting study of Multiple Myeloma and Lymphoma, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04300998 is a study of Multiple Myeloma and Lymphoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 154 participants, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04300998, a study of Multiple Myeloma and Lymphoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to find out how older patients respond to CAR-T cell therapy and how the treatment affects their quality of life. This is a quality of life study and participating in the study does not involve receiving any treatment, other than the standard treatment for participants' disease.
Primary Outcome
Participants who complete all assessment visits prior to disease progression or death will be considered as a success for a feasibility endpoint.
Conditions Studied
Interventions
- BEHAVIORAL Activities of Daily Living/ADLs
- BEHAVIORAL Instrumental Activity of Daily Living
- BEHAVIORAL Timed Up and Go
- BEHAVIORAL Cognition
- BEHAVIORAL Geriatric Depression Scale
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2020-03-04 |
| Est. Completion | 2026-03-04 |
What NCT04300998 shows while recruiting
NCT04300998 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 546-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (72% lower).
The record links to 6 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 5 interventions - of which Activities of Daily Living/ADLs is the first listed.
NCT04300998 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04300998 about?
NCT04300998 is a clinical study titled "Study of CAR-T Therapy in Older Patients". This study is being done to find out how older patients respond to CAR-T cell therapy and how the treatment affects their quality of life. This is a quality of life study and participating in the study does not involve receiving any treatment, other than the standard treatment for participants' dise...
What is the current status of trial NCT04300998?
This trial is currently recruiting. The enrollment target is 154 participants. The study started on 2020-03-04. Estimated completion is 2026-03-04.
What conditions does trial NCT04300998 study?
This clinical trial studies the following conditions: Multiple Myeloma, Lymphoma, Lymphoma, B-Cell, High Grade B-Cell Lymphoma, Dlbcl NOS.
What interventions are being tested in trial NCT04300998?
The interventions under investigation include: Activities of Daily Living/ADLs (BEHAVIORAL), Instrumental Activity of Daily Living (BEHAVIORAL), Timed Up and Go (BEHAVIORAL), Cognition (BEHAVIORAL), Geriatric Depression Scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT04300998?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04300998 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04300998's enrollment target sits among peer trials
154 132nd of 438 higher than 307 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
- NCT05599750 · 154 participants · NA
Suture Repair vs Mesh Repair for Incisional Hernia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI